ARAY — Accuray Incorporated

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Revenue: $102.2 million, down 12% year-over-year and down 13% on a constant currency basis.
• Product Revenue: $45 million, down 26% overall and down 28% on a constant currency basis, primarily impacted by lower sales in China.
• Service Revenue: $57.2 million, up 4% year-over-year and up 3% on a constant currency basis, indicating resilience in the service segment.
• Gross Margin: Overall gross margin at 23.5%, down from 36.1% in the prior year; product gross margins fell to 19.7% from 43.5% due to tariff impacts and product mix.
• Operating Loss: $11.6 million, compared to a profit of $4.7 million in the prior year.
• Adjusted EBITDA: Loss of $1.9 million, down from a positive $9.6 million year-over-year.
• Cash Position: Total cash and equivalents decreased to $41.9 million from $63.9 million in the previous quarter.

2. Strategic Updates and Business Highlights

• Transformation Plan: Announced a comprehensive operational and organizational transformation aimed at improving accountability, cost control, and execution. This includes a 15% workforce reduction expected to yield $12 million in benefits for fiscal 2026.
• Service Portfolio Expansion: Initiatives to diversify service offerings and enhance customer engagement are underway, focusing on solutions-oriented services that drive recurring revenue.
• Distributor Partnerships: Implementing a structured management program for distributors to improve commercial execution and align performance standards.
• Operational Improvements: Emphasis on tightening financial and operational reviews to enhance accountability and execution pace.

3. Forward Guidance and Outlook

• Revised Revenue Guidance: Expected revenue range for fiscal 2026 adjusted to $440 million to $450 million, down from $471 million to $485 million.
• Adjusted EBITDA Guidance: Revised to $22 million to $25 million, down from $31 million to $35 million.
• Long-term Goals: Aiming for a high single-digit adjusted EBITDA margin run rate within nine months, with aspirations to reach double-digit margins over the medium to long term.

4. Bad News, Challenges, or Points of Concern

• External Headwinds: Ongoing tariffs and geopolitical instability, particularly related to China, have negatively impacted demand and commercial activity.
• Declining Product Margins: Significant drop in product gross margins due to tariff impacts, product mix, and lower margin releases from China.
• Revenue Decline: The overall revenue decline raises concerns about the company's growth trajectory amidst challenging market conditions.

5. Notable Q&A Insights

• Revenue Guidance Cut: Management clarified that the cautious outlook is primarily due to the impact of tariffs and geopolitical factors affecting demand in China, leading to delays in deal dynamics.
• Product Gross Margins: Expected to remain under pressure due to tariffs and inflation, with future margins projected between 20% to 30%, contingent on product mix and timing of releases.
• CapEx Environment: Hospital customers are not showing signs of reduced capital expenditures, indicating potential for future equipment purchases.

Overall, Accuray's Q2 2026 results reflect significant challenges due to external factors, but the company is actively pursuing strategic initiatives to enhance its operational efficiency and service offerings, aiming for long-term growth and profitability.